QUARLINTAN õhukese polümeerikattega tablett Эстония - эстонский - Ravimiamet

quarlintan õhukese polümeerikattega tablett

medis ehf. - irbesartaan - õhukese polümeerikattega tablett - 75mg 28tk

QUARLINTAN õhukese polümeerikattega tablett Эстония - эстонский - Ravimiamet

quarlintan õhukese polümeerikattega tablett

medis ehf. - irbesartaan - õhukese polümeerikattega tablett - 150mg 28tk

Entresto Европейский союз - эстонский - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - südamepuudulikkus - angiotensiin ii antagonistidega, muud kombinatsioonid, toimivad ained renin-angiotensiini süsteemi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis Европейский союз - эстонский - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - südamepuudulikkus - reniini-angiotensiini süsteemi toimivad ained - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.